Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies

被引：1

作者：

Zha, Chenyu ^{[1
,2
]}

Yang, Xinyu ^{[1
,2
]}

Yang, Jun ^{[1
,2
]}

Zhang, Yujie ^{[1
]}

Huang, Rui ^{[1
]}

机构：

[1] Southern Med Univ, Zhujiang Hosp, Dept Hematol, Guangzhou, Guangdong Provi, Peoples R China

[2] Southern Med Univ, Sch Clin Med 2, Guangzhou, Guangdong, Peoples R China

来源：

ANNALS OF HEMATOLOGY | 2024年 / 103卷 / 12期

基金：

中国国家自然科学基金;

关键词：

Acute myeloid leukemia; Immunosuppression; Immunotherapy; Targeted therapy; REGULATORY T-CELLS; BONE-MARROW MICROENVIRONMENT; INDOLEAMINE 2,3-DIOXYGENASE; METABOLIC-REGULATION; AML PATIENTS; CANCER; INHIBITION; MACROPHAGES; IMMUNOTHERAPY; CHEMOTHERAPY;

D O I：

10.1007/s00277-024-06117-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Similar to other malignancies, immune dysregulation is a key feature of acute myeloid leukemia (AML), manifesting as suppressed anti-leukemia immune cells, immune evasion by leukemia blasts, and disease progression. Various immunosuppressive factors within the AML microenvironment contribute to the weakening of host immune responses and the efficacy of cellular immunotherapy. To address these challenges, strategies targeting immunosuppressive elements within the AML microenvironment aim to bolster host or adoptive immune effector cells, ultimately enhancing leukemia treatment. Additionally, the off-target effects of certain targeted drugs (venetoclax, sorafenib, ivosidenib, etc.) may also positively impact anti-AML immunity and immunotherapy. This review provides an overview of the immunosuppressive factors present in AML microenvironment and the strategies developed to rescue immune cells from immunosuppression. We also outline how targeted agents can alter the immune landscape in AML patients, and discuss the potential of targeted drugs to benefit host anti-leukemia immunity and immunotherapy for AML.

引用

页码：4883 / 4899

页数：17

共 167 条

[1] Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance [J].

Abacka, Hannah ;

Hansen, Jesper S. ;

Huang, Peng ;

Venskutonyte, Raminta ;

Hyrenius-Wittsten, Axel ;

Poli, Giulio ;

Tuccinardi, Tiziano ;

Granchi, Carlotta ;

Minutolo, Filippo ;

Hagstrom-Andersson, Anna K. ;

Lindkvist-Petersson, Karin .

HAEMATOLOGICA, 2021, 106 (04) :1163-1166

[2] Glucose transporters in cancer metabolism [J].

Adekola, Kehinde ;

Rosen, Steven T. ;

Shanmugam, Mala .

CURRENT OPINION IN ONCOLOGY, 2012, 24 (06) :650-654

[3] Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells [J].

Agarwal, Sangya ;

Aznar, M. Angela ;

Rech, Andrew J. ;

Good, Charly R. ;

Kuramitsu, Shunichiro ;

Da, Tong ;

Gohil, Mercy ;

Chen, Linhui ;

Hong, Seok-Jae Albert ;

Ravikumar, Pranali ;

Rennels, Austin K. ;

Salas-Mckee, January ;

Kong, Weimin ;

Ruella, Marco ;

Davis, Megan M. ;

Plesa, Gabriela ;

Fraietta, Joseph A. ;

Porter, David L. ;

Young, Regina M. ;

June, Carl H. .

IMMUNITY, 2023, 56 (10) :2388-2407.e9

[4] Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction [J].

Agha, Douaa Moussa ;

Rouas, Redouane ;

Najar, Mehdi ;

Bouhtit, Fatima ;

Fayyad-Kazan, Hussein ;

Lagneaux, Laurence ;

Bron, Dominique ;

Meuleman, Nathalie ;

Lewalle, Philippe ;

Merimi, Makram .

CELLS, 2020, 9 (09) :1-18

[5] Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner [J].

Al-Matary, Yahya S. ;

Botezatu, Lacramioara ;

Opalka, Bertram ;

Hoenes, Judith M. ;

Lams, Robert F. ;

Thivakaran, Aniththa ;

Schuette, Judith ;

Koester, Renata ;

Lennartz, Klaus ;

Schroeder, Thomas ;

Haas, Rainer ;

Duehrsen, Ulrich ;

Khandanpour, Cyrus .

HAEMATOLOGICA, 2016, 101 (10) :1216-1227

[6] The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation [J].

Amaya, Maria L. ;

Inguva, Anagha ;

Pei, Shanshan ;

Jones, Courtney ;

Krug, Anna ;

Ye, Haobin ;

Minhajuddin, Mohammad ;

Winters, Amanda ;

Furtek, Steffanie L. ;

Gamboni, Fabia ;

Stevens, Brett ;

D'Alessandro, Angelo ;

Pollyea, Daniel A. ;

Reigan, Philip ;

Jordan, Craig T. .

BLOOD, 2022, 139 (04) :584-596

[7] Tumour microenvironment factors shaping the cancer metabolism landscape [J].

Anastasiou, Dimitrios .

BRITISH JOURNAL OF CANCER, 2017, 116 (03) :277-286

[8] Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein [J].

Bachanova, Veronika ;

Cooley, Sarah ;

Defor, Todd E. ;

Verneris, Michael R. ;

Zhang, Bin ;

McKenna, David H. ;

Curtsinger, Julie ;

Panoskaltsis-Mortari, Angela ;

Lewis, Dixie ;

Hippen, Keli ;

McGlave, Philip ;

Weisdorf, Daniel J. ;

Blazar, Bruce R. ;

Miller, Jeffrey S. .

BLOOD, 2014, 123 (25) :3855-3863

[9] Cytarabine-induced TNFα promotes the expansion and suppressive functions of myeloid-derived suppressor cells in acute myeloid leukaemia [J].

Bai, Hua ;

Peng, Yuhui ;

Li, Yi ;

Duan, Juanjuan ;

Fu, Wenli ;

Liang, Xinming ;

Yu, Wenfeng ;

Zhang, Qifang .

SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2022, 95 (06)

[10] Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets [J].

Bizymi, Nikoleta ;

Bjelica, Suncica ;

Kittang, Astrid Olsnes ;

Mojsilovic, Slavko ;

Velegraki, Maria ;

Pontikoglou, Charalampos ;

Roussel, Mikael ;

Ersvaer, Elisabeth ;

Santibanez, Juan Francisco ;

Lipoldova, Marie ;

Papadaki, Helen A. .

HEMASPHERE, 2019, 3 (01)

← 1 2 3 4 5 6 7 8 9 10 →